Veno-occlusive disease/sinusoidal obstruction syndrome in patients with prior gemtuzumab ozogamicin: literature analysis of survival after defibrotide treatment

od Richardson, Paul G., Corbacioglu, Selim
izdano v Blood Cancer J (2020)

Promising therapies in multiple myeloma

od Bianchi, Giada, Richardson, Paul G., Anderson, Kenneth C.
izdano v Blood (2015)

Mechanism of Action of Proteasome Inhibitors and Deacetylase Inhibitors and the Biological Basis of Synergy in Multiple Myeloma

od Hideshima, Teru, Richardson, Paul G., Anderson, Kenneth C.
izdano v Mol Cancer Ther (2011)

Bortezomib in the treatment of multiple myeloma

od Ghobrial, Irene M., Richardson, Paul G., Anderson, Kenneth C.
Izdano 2011

Optimizing therapy for del(17p) multiple myeloma

od Avet-Loiseau, Hervé, Richardson, Paul G., di Bacco, Alessandra
izdano v Oncotarget (2017)

The use of defibrotide in blood and marrow transplantation

od Richardson, Paul G., Carreras, Enric, Iacobelli, Massimo, Nejadnik, Bijan
izdano v Blood Adv (2018)

A review of lenalidomide in combination with dexamethasone for the treatment of multiple myeloma

od Hideshima, Teru, Raje, Noopur, Richardson, Paul G, Anderson, Kenneth C
Izdano 2008

From the bench to the bedside: emerging new treatments in multiple myeloma

od Mitsiades, Constantine S., Hayden, Patrick J., Anderson, Kenneth C., Richardson, Paul G.
Izdano 2007

Peripheral neuropathy in multiple myeloma patients receiving lenalidomide, bortezomib, and dexamethasone (RVD) therapy

od Voorhees, Peter M., Laubach, Jacob, Anderson, Kenneth C., Richardson, Paul G.
izdano v Blood (2013)

Pulmonary and Hepatic Complications of Hematopoietic Cell Transplantation

od Yanik, Gregory A., Cooke, Kenneth R., Ho, Vincent T., Richardson, Paul G.
izdano v Hematopoietic Cell Transplantation in Children with Cancer (2013)

A clinical perspective on plasma cell leukemia; current status and future directions

od Tuazon, Sherilyn A., Holmberg, Leona A., Nadeem, Omar, Richardson, Paul G.
izdano v Blood Cancer J (2021)

Kidney Disease and Multiple Myeloma

od Heher, Eliot C., Rennke, Helmut G., Laubach, Jacob P., Richardson, Paul G.
Izdano 2013

Perifosine, an oral, anti-cancer agent and inhibitor of the Akt pathway: mechanistic actions, pharmacodynamics, pharmacokinetics, and clinical activity

od Richardson, Paul G, Eng, Cathy, Kolesar, Jill, Hideshima, Teru, Anderson, Kenneth C
izdano v Expert Opin Drug Metab Toxicol (2012)

Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad?

od Plesner, Torben, van de Donk, Niels W. C. J., Richardson, Paul G.
izdano v Cells (2020)

Imaging Features of Extramedullary, Relapsed, and Refractory Multiple Myeloma involving the Liver Across Treatment With Cyclophosphamide, Lenalidomide, Bortezomib, and Dexamethason...

od Saboo, Sachin S., Fennessy, Fiona, Benajiba, Lina, Laubach, Jacob, Anderson, Kenneth C., Richardson, Paul G.
izdano v J Clin Oncol (2012)

Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan failure

od Richardson, Paul G, Grupp, Stephan A, Pagliuca, Antonio, Krishnan, Amrita, Ho, Vincent T, Corbacioglu, Selim
izdano v Int J Hematol Oncol (2017)

Emerging therapies for multiple myeloma

od Podar, Klaus, Tai, Yu-Tzu, Hideshima, Teru, Vallet, Sonia, Richardson, Paul G, Anderson, Kenneth C
Izdano 2009

Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myeloma

od Chauhan, Dharminder, Singh, Ajita V., Ciccarelli, Bryan, Richardson, Paul G., Palladino, Michael A., Anderson, Kenneth C.
Izdano 2010

How I treat plasma cell leukemia

od van de Donk, Niels W. C. J., Lokhorst, Henk M., Anderson, Kenneth C., Richardson, Paul G.
Izdano 2012

New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase Inhibitors

od Cea, Michele, Cagnetta, Antonia, Gobbi, Marco, Patrone, Franco, Richardson, Paul G., Hideshima, Teru, Anderson, Kenneth C.
Izdano 2013